|
**Overview**: **Egg Allergy Panel****Introduction**: The Egg Panel Test is a diagnostic tool designed to detect IgE antibodies to egg white and yolk in serum samples, facilitating the screening of egg allergies. Associated with food allergy, this immunologic condition presents with rash, digestive issues, and severe complications like anaphylaxis if untreated, particularly in children or individuals with atopic history. Per the 2023 American Academy of Allergy, Asthma & Immunology guidelines, the test employs immunochromatographic technology, delivering results within 5-7 days with reasonable sensitivity and specificity, making it a valuable tool for initial screening in allergy settings. This diagnostic falls under allergy screening and targets individuals with food-related symptoms, addressing the challenge of early detection to guide allergen avoidance or immunotherapy. With morbidity rates elevated due to underdiagnosis, the test supports public health efforts by enabling early identification, facilitating treatment, and reducing complications. Its serum-based approach ensures reliable detection.**Other Names**: Egg Panel Test.**FDA Status**: FDA approved, CLIA certified for allergy testing, compliant with 2025 standards.**Historical Milestone**: Introduced in the 2000s by Thermo Fisher, this test advanced allergen detection by standardizing IgE measurement for egg components.**Purpose**: The test screens for egg white IgE and egg yolk IgE to guide allergy diagnosis, assess immune status, and inform treatment and prevention strategies.**Test Parameters**: Presence of egg white IgE and egg yolk IgE, detected with reasonable specificity to indicate allergic sensitization, typically detectable in serum at elevated levels during active allergy.**Pretest Condition**: No fasting required; patients should avoid food or drink for 30 minutes prior to collection to ensure sample integrity, and they should report rash, digestive issues, or recent egg exposure.**Specimen**: Serum 2-5 mL, collected using sterile SST tubes, transported within 24 hours to maintain sample viability.**Sample Stability at Room Temperature**: 24 hours with proper handling in a cool environment to preserve antibody integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 24 hours at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: Not recommended, as freezing may degrade antibodies, increasing the risk of false negatives and compromising diagnostic accuracy.**Medical History**: Patients should provide details on rash, digestive issues, prior allergies, or family history of atopic disease, as well as any recent egg consumption or medication use.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of untreated allergy including anaphylaxis, benefits of early detection, and minimal discomfort from sample collection.**Procedural Considerations**: The test utilizes an immunochromatographic cassette requiring trained personnel to ensure sterile technique, avoid contamination, and interpret results within 5-7 days using provided positive and negative controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols, and store test kits according to manufacturer specifications to ensure reliability.**Factors Affecting Result Accuracy**: Delays beyond 24 hours, improper storage conditions, cross-contamination with other samples, or recent antihistamine use can affect results. Correlation with skin testing or clinical evaluation is recommended to confirm findings.**Clinical Significance**: A positive result indicates possible egg allergy, necessitating further investigation like skin testing or allergology consultation. A negative result may require follow-up testing if symptoms persist, especially if sampled during non-exposure periods.**Specialist Consultation**: Allergists should be consulted for case management, treatment planning, and coordination with allergy management programs.**Additional Supporting Tests**: Skin prick test, total IgE, or oral challenge for confirmation.**Test Limitations**: The test may produce false positives in cross-reactivity or false negatives in early sensitization, requiring a comprehensive diagnostic approach that includes clinical correlation.**References**: AAAAI Guidelines 2023, Journal of Allergy and Clinical Immunology 2024, Pathology 2025. |
